Amphetamine, past and present--a pharmacological and clinical perspective
about
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyWeight management in obesity - past and presentDevelopment of an on-animal separation-based sensor for monitoring drug metabolism in freely roaming sheepRisk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.ANI-1: an extensible neural network potential with DFT accuracy at force field computational cost.The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention.The effect of methamphetamine on an animal model of erectile function.Wake-promoting pharmacotherapy for psychiatric disorders.Relation of the multilocus genetic composite reflecting high dopamine signaling capacity to future increases in BMI.Psychostimulants and movement disorders.Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom StudyAmphetamines, new psychoactive drugs and the monoamine transporter cycle.Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trialPsychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms.Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls.Current Trends in Identifying Rapidly Acting Treatments for DepressionEffects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial.Optogenetic activation of dopamine neurons in the ventral tegmental area induces reanimation from general anesthesia.Methamphetamine addiction: potential substitute treatment.Enhancing attention in neurodegenerative diseases: current therapies and future directions.Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China.Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.ADHD pharmacogenetics across the life cycle: New findings and perspectives.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder.Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives.Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.Epidemiology of Obesity and Pharmacologic Treatment Options.The safety of extended-release drug formulations for the treatment of ADHD.Drugs, games, and devices for enhancing cognition: implications for work and society.Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction.Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model.Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.
P2860
Q26750486-572CB234-105B-4D55-9DD1-B043B97326B6Q26774747-DE1C8B54-DC7D-4AED-8812-CA7575FA6185Q27336031-8C17C8D4-B7E1-4DC2-BB14-6CBA89171DC8Q30234520-D9E7A3CE-CD93-4498-855A-61C101C4F2D0Q33631061-124558CB-4883-4272-8CD9-7BB4E3C8942BQ33802902-1C0E0A5B-BDD5-4ACF-816C-09BB620311D7Q34117817-24B527A8-CD8D-463C-A3D5-91C48ED696D6Q34443394-9199C5EC-7F28-4196-9843-AA32561C7095Q35096920-FEC61175-9BCB-4C67-A763-B3FC51BC8AFCQ35489276-0860F97F-A0E5-46F8-A4CF-EC1A485CE848Q35566736-E61D5695-CCF2-46D0-A7B0-1FBE52A50863Q35816558-9BA1A856-7390-49AB-9B3D-4FB5444CA78DQ35853599-3FF3AC43-29A5-404F-BEF5-D3E230ACB6CFQ35875805-BF5A395C-DD58-4261-A3A2-CC69243BE4CAQ36144909-E9F81409-A3B4-4B31-9655-81ED208202ADQ36372705-598ADB27-2F17-4A8D-8F75-913420BB1A15Q36411331-F21A1F71-A796-431A-9120-1A0C16FAEE9DQ36446854-4A234B56-7BE5-4F32-AA84-C1D2917F2A10Q37005009-38B64AAC-0530-4A11-88CF-3FDA184BE19CQ37210886-62EC9EE5-6C19-46B7-AE7B-895B9A13062BQ37375548-A540BF0F-EA52-4936-92FE-BC006C7C7F52Q37417899-53614249-DF76-4D6B-A802-99DCE8AB7184Q37514640-9D36CC67-D317-46F1-B780-195EE72DC4FFQ37585464-2BA5F862-0C93-4A39-AC66-0253DE3B4E27Q37731795-D1D03F81-9723-43A4-873C-A7A74226DCB3Q38187892-745C10D9-5D69-4A39-BAF9-B26309884C7FQ38209972-E308E0A3-9496-479F-A2DA-5DE1EF781DB0Q38221823-7D16A831-A542-40CA-B4CF-C369C06E3B0CQ38229065-00C6EC2B-13DD-4446-86C0-CD295E2D6283Q38242438-BA4413C3-5C4C-4689-A17E-B0F0986C6DC1Q38370764-1B14D5B1-A542-4657-8ABA-587D66577CA5Q38372945-291B1E2C-F58E-4809-8F8B-F335DA82EF0EQ38664308-42ECC2F3-7374-4957-8E06-095FCC9D35F4Q38710913-0E96F784-6863-4C2F-8801-6CB11439DCA8Q38717129-AC2D11B8-78E3-489D-8D79-6FE8D74C0F00Q38732635-CF2308CC-6AD6-41B4-A979-4CBF1AC8605BQ38797653-9CB44327-FBDB-45BE-AFDF-A90B7A13FE0BQ38820699-0BEF66B7-259B-4CB7-800B-611359EFB29FQ39773112-08A182A8-7317-456D-A99C-219EF61F9DA3Q41312831-E54ACB7C-E324-447A-B86C-C5F2AA10137D
P2860
Amphetamine, past and present--a pharmacological and clinical perspective
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Amphetamine, past and present--a pharmacological and clinical perspective
@ast
Amphetamine, past and present--a pharmacological and clinical perspective
@en
Amphetamine, past and present--a pharmacological and clinical perspective
@nl
type
label
Amphetamine, past and present--a pharmacological and clinical perspective
@ast
Amphetamine, past and present--a pharmacological and clinical perspective
@en
Amphetamine, past and present--a pharmacological and clinical perspective
@nl
prefLabel
Amphetamine, past and present--a pharmacological and clinical perspective
@ast
Amphetamine, past and present--a pharmacological and clinical perspective
@en
Amphetamine, past and present--a pharmacological and clinical perspective
@nl
P2093
P2860
P921
P3181
P356
P1476
Amphetamine, past and present--a pharmacological and clinical perspective
@en
P2093
David J Heal
Jane Gosden
Sharon L Smith
P2860
P304
P3181
P356
10.1177/0269881113482532
P407
P50
P5008
P577
2013-06-01T00:00:00Z